Factors Associated with Lipoprotein Cholesterol Levels
|
|
- Lester Myron Joseph
- 5 years ago
- Views:
Transcription
1 Factors Associated with Lipoprotein Cholesterol Levels The Framingham Study Peter W. F. Wilson, Robert J. Garrison, Robert D. Abbott, and William P. Castelli Lipoprotein cholesterol determinations in 6328 individuals aged 20 to 79 years in the Framingham Heart Study Cohort and Offspring were related by multiple regression analysis to reported cigarette smoking, alcohol intake, and (wf ht 2 ). Cigarette smoking was found to be strongly associated with "atherogenic" lipoprotein cholesterol profiles in young adults, and particularly in women. The associations for alcohol intake were mostly uniform across age s and lipoprotein cholesterol fractions, while coefficients for varied considerably. Blood chemistry associations were studied in participants under 50 years, after controlling for smoking,, and alcohol intake. Significant associations for high density lipoprotein cholesterol (HDL-C) were seen for both sexes with alkaline phosphatase, serum calcium, serum uric acid, and leucocyte count. Low density lipoprotein cholesterol (LDL-C) associations were observed with calcium, hematocrit, lactate dehydrogenase, and leucocyte count in men and women, while very low density lipoprotein cholesterol (VLDL-C) associations occurred with alkaline phosphatase, glucose, uric acid, and leucocyte count in both sexes. A 1 mg/dl higher calcium corresponded to an HDL-C approximately 4 mg/dl greater and a LDL-C typically 6 mg/ dl greater after controlling for 12 other variables. A 1000/ml increase in leucocyte count was typically associated with a decrease in HDL-C by 1 mg/dl and an increase in LDL-C and VLDL-C of 1 mg/dl each. (Arteriosclerosis 3: , May/June 1983) Recent research strongly suggests that lipoprotein metabolism is intimately linked to the atherosclerotic process. These findings prompted numerous investigators to study the biological concomitants of lipoprotein measurements. 1 " 3 Most of these reports have concentrated on only a few variables at a time and dealt with relatively small populations. In the Framingham Heart Study, lipoprotein cholesterols were determined in individuals aged 20 to 79 years during 1971 to An extensive medical history was taken and physical examination performed, which allowed us to examine the multivariate association of obesity, alcohol, cigarette smoking, and drug intake with lipoprotein cholesterol levels for men and women whose ages spanned six decades. Automat- From the Epidemiology and Biometry Program, National Heart, Lung, and Blood Institute, Bethesda, Maryland, and the Heart Disease Epidemiology Study, National Heart, Lung, and Blood Institute, Framingham, Massachusetts. Address for reprints: Dr. Peter W. F. Wilson, National Heart, Lung, and Blood Institute, Federal Building, Room 300, Bethesda, Maryland Received July 27,1982; revision accepted December 7, ed chemistry and hematology tests were performed for the younger one-half of the population. This additional information provided the basis to investigate potential relationships between individual lipoprotein cholesterols and these other factors. Methods The population studied included 2217 men and women from the Framingham Heart Study Cohort which has been followed with biennial exams since 1949, and 4197 men and women from the Framingham Offspring Study at the time of their first examination from 1971 to The Cohort participants in this report include men and women aged 50 to 79 years old who were free from coronary heart disease at the time of the eleventh biennial examination. Women taking estrogen preparations were excluded from all analyses. The Offspring participants included men and women aged 20 to 49 years, subject to the same restrictions as the Cohort. The data collection for both the Cohort and Offspring s consisted of a full medical history,
2 274 ARTERIOSCLEROSIS VOL 3, No 3, MAY/JUNE 1983 physical examination, and fasting lipoprotein cholesterol determinations using a modified Lipid Research Clinics (LRC) protocol. 4 Current cigarette smoking history and the usual intake of cans of beer, glasses of wine, and cocktails per week were included in the medical history. The weekly alcohol intake was calculated for each individual using the following equation: intake (oz/wk) = (weekly number of 12 oz cans of beer x 0.444) + (weekly number of 4 oz glasses of wine x 0.400) + (weekly number of 1.5 oz liquor cocktails x 0.570). 5 The was computed for each individual by dividing the subject's weight in kilograms by his or her height in meters raised to the second power. A manual Abell-Kendall method was used to measure cholesterol, 6 and triglycerides were determined by the AAI modification of the Kessler-Lederer method. 7 High density lipoprotein cholesterol (HDL- C) was measured after precipitation of other lipoproteins with heparin-manganese. Low density lipoprotein cholesterol (LDL-C) was determined by subtracting HDL-C from the bottom fraction cholesterol, performed after reconstitution of the bottom fraction following preparative ultracentrifugation of EDTA plasma at serum density. The very low density lipoprotein cholesterol (VLDL-C) was calculated by subtracting the bottom fraction cholesterol from total cholesterol. 4 If the calculated VLDL-C value was negative, it was arbitrarily set at zero. Automated blood chemistries (SMA 12/60) and hematology tests using a Coulter Counter were performed on the Offspring at the Framingham Union Hospital clinical chemistry laboratory. Statistical methods included use of a standard multiple linear regression model using least squares estimation for Tables A multivariate regression model derived from a backward selection procedure generated Tables Factors used in this analysis included current cigarette smoking (yes or no),, alcohol intake per week, serum albumin, serum alkaline phosphatase, blood urea nitrogen (BUN), serum calcium, serum globulin, plasma glucose, lactate dehydrogenase (LDH), serum phosphorus, serum glutamic oxaloacetic transaminase (SGOT), serum uric acid, blood hemoglobin, and leucocyte count. Results The mean values and their standard deviations for the frequency of smoking,, and alcohol intake are displayed in Table 1 for men and Table 2 for women. Among the men, each variable shows Table 1. Mean Values and Standard Deviations for Frequency,, and Intake In Framingham Men Years 40-^9 Number Current smoking Proportion Mean (kg/sq m) Mean intake (oz/wk) Table 2. Mean Values and Standard Deviations for Frequency,, and Intake In Framingham Women Years qroup Number Current smoking Proportion Mean (kg/sq m) Mean intake (oz/wk)
3 ASSOCIATIONS WITH LIPOPROTEIN CHOLESTEROLS Wilson et al. 275 different cross-sectional trends with age. frequency decreased, rose at least through the sixth decade, and alcohol intake peaked in the 40 to 49 year age. Table 2 shows that the smoking frequency for women paralleled that for the men, while the increased gradually over the six decades examined. Reported alcohol intake for the women was less than one-half that of the men, with a maximum intake in the middle age s. The results of multiple regression analyses for each of the lipoprotein cholesterol fractions are shown in Tables 3 to 12. The gender-specific analyses are presented for each 10-year age and for the total sample in Tables 3 to 8. The estimated multiple regression coefficients for HDL-C appear in Table 3 for men and Table 4 for women. From an inspection of the coefficients for the total male population, current smoking was associated with an HDL- C that was 3.2 mg/dl lower in nonsmokers. A significant inverse association was also found for the in all s. Overall, each unit increment in this index of adiposity was accompanied by a 0.8 mg/dl decrement in HDL-C. exerted its effect in the opposite direction. Each additional ounce of alcohol consumed showed a concomitant 0.4 mg/dl increase in HDL-C. Analysis by 10-year age conforms to the pattern discussed for the total population. The strength of associations indicated by the multiple regression coefficient estimates is seen among most of the age s, with uniformity in the estimates the rule, despite the relatively small values of the multiple values, which range from 0.08 to The results in Table 4 paralleled those for men, with few exceptions. The individual variables manifested their effect in the same direction as before, but the magnitude of the coefficients differed. The coefficients were very similar in men and women, but appeared to be slightly larger for smoking, and approximately twice as large in women for alcohol. Women who smoke tended to have HDL-C levels 5.0 mg/dl less than their nonsmoking peers. For each ounce of alcohol consumed, the HDL-C for these women was 0.9 mg/dl greater. Table 5 and 6 present the regression results for LDL-C. The low values for the multiple s, especially for individuals older than 40 years, demonstrates that prediction of LDL-C with this model is quite weak. For the total male and female popula- Table 3. Regression Coefficients of Selected Variables for HDL Cholesterol by 10-Year Group In Framingham Men 66.64: 62.1* 58.7* 72.7* 64.3* * * < : p < to.001 < p <. *p< * -3.8* -2.4f -2.7* * -0.9* -0.7* -0.6* -1.1* -0.8* -1.6* -0.8* 0.6* 0.5* 0.5* 0.5* 0.7* 0.8* 0.4* 0.16* 0.11* 0.10* 0.16* 0.11* 0.08* 0.12* Table 4. Regression Coefficients of Selected Variables for HDL Cholesterol by 10-Year Group In Framingham Women 67.7* 71.9* 80.9* 77.8* 79.5* 81.1* 72.4* t0.001 < p<. -4.3* -4.6* -6.2* -5.9* * -0.5* -0.7* -0.9* -0.7* -0.9* -1.0* -0.6* 0.5f 0.9* 1.1* 1.0* 1-0t * 0.07* 0.10* 0.14* 0.10* 0.09* 0.09* 0.08*
4 276 ARTERIOSCLEROSIS VOL 3, No 3, MAY/JUNE 1983 Table 5. Regression Coefficients of Selected Variables for LDL Cholesterol by 10-Year Group In Framingham Men 67.3* 96.9* 135.8* 123.0* 115.9* 149.0f 99.8* * < p < t0.001 < p< * 1.3* * -0.7* * 0.02* Table 6. Regression Coefficients of Selected Variables for LDL Cholesterol by 10-Year Group In Framingham Women 88.4* 79.0* 95.2* 149.6* 140.4* 154.7* 81.8* * < p < fo.001 < p< * 7.9t * 1.4* 1.3* * -1.2f * t 0.03f 0.06* 0.05* 0.02* 0.06* tions, the was positively associated with levels of LDL-C, but these associations were found only in the youngest male and female age s. was positively associated with LDL-C in women younger than 60 years, and a suggestion of a negative relationship was present in the older s. A similar pattern was seen for the men. intake also showed a largely negative association with LDL-C for women. This association was significant overall for women, but not for men. Although no statistically significant association was found, the data suggest an inverse relationship between alcohol intake and LDL-C for men as well. Tables 7 and 8 show the regressions for VLDL-C. The was significantly associated with VLDL-C in the younger age s. was Table 7. Regression Coefficients of Selected Variables for VLDL Cholesterol by 10- Year Group In Framingham Men t * < p < t0.001 < p<. *p < f * 1.0* 1.1* 0.9t * 0.3* * 0.11* 0.05* 0.04* 0.02* 0.04*
5 ASSOCIATIONS WITH LIPOPROTEIN CHOLESTEROLS Wilson et al. 277 Table 8. Regression Coefficients of Selected Variables for VLDL Cholesterol by 10- Year Group In Framlngham Women 8.2* 5.0* * 25.5* * 2.9* 3.4* t 0.4* 0.4* * 0.04* 0.03* * * * 3444 * < p < fo.001 < p<. also significantly related to VLDL-C among younger women, but among men the association was only significant for those 30 to 39 years old. The magnitude of the regression coefficient estimates for the men was always greater than that among women for the smoking and variables in the overall VLDL-C analysis. There was only a slight positive association of alcohol intake with VLDL-C in men, and none for women. Table 9 lists the multiple regression coefficients for the number of cigarettes smoked per day from the model that regresses total cholesterol and its lipoprotein cholesterol fractions on alcohol intake,, and cigarette number. In 20- to 49-year-old men and women, cigarette number and HDL-C were strongly associated in an independent fashion, as Table 9. Regression Coefficients for Number of Cigarettes In Regression Model Estimating Llpoproteln Cholesterol Fractions LJpoprotein cholesterol HDL-C LDL-C VLDL-C (20-^9 yrs) Men Women -0.11* -0.25* 0.16t 0.33* 0.12* 0.13* (50-79 yrs) Men Women -0.10t -0.20* * 0.21* * Model: cholesterol = f(alcohol intake,, number of cigarettes). * < p < fo.001 < p<. Table 10. Regression Coefficients of Plasma Chemistry, Hematologic, and Selected Variables for HDL Cholesterol In Framlngham Offspring Years Men Women Variable Current smoking (kg/sq m) (oz/wk) Albumin (g/100 ml) Alkaline phosphatase (ILJ/liter) Urea nitrogen (mg/100 ml) Calcium (mg/dl) Globulin (g/100 ml) Glucose (mg/100 ml) Hematocrit (ml/100 ml) LDH (U/ml) Phosphorus (mg/100 ml) SGOT (U/ml) Uric acid (mg/100 ml) Leucocyte count (1000/ml) Number -2.26* -0.60* 0.53* t 0.15* 2.90* * * -0.75* * -0.57* 0.54* -0.05* 2.56* -0.04* -0.67f -0.79* * -0.51* 0.98* * 0.28* 5.27* f -0.46* * -0.51* 0.97* -2.25* -0.07* 0.28* 5.65* -1.03t -0.41* 0.14 * < p < t0.001 < p<. *p <
6 278 ARTERIOSCLEROSIS VOL 3, No 3, MAY/JUNE 1983 Table 11. Regression Coefficients of Plasma Chemistry, Hematologic, and Selected Variables for LDL Cholesterol In Framlngham Offspring Years Men Women Variable Current smoking (kg/sq m) (oz/wk) Albumin (g/100 ml) Alkaline phosphatase (lu/liter) Urea nitrogen (mg/100 ml) Calcium (mg/dl) Globulin (g/100 ml) Glucose (mg/100 ml) Hematocrit (ml/100 ml) LDH (U/ml) Phosphorus (mg/100 ml) SGOT (U/ml) Uric acid (mg/100 ml) Leucocyte count (1000/ml) Number * < p < < p<. *p < : f * * 0.08t -5.44f : : : 6.16f 0.69* 0.08f -5.38t -0.09* 1.794: * 1.204: : * 0.724: 7.21t 4.82* 0.12* 1.464: 0.07t * t 1.104: : 0.12* 0.734: 6.35t 5.39f 0.12* 1.344: 0.08f 0.90* 0.13 previously reported. 12 The number of cigarettes reported was also associated independently with the other lipoprotein cholesterol fractions. The associations were negative for HDL-C and positive for LDL- C, VLDL-C, and total cholesterol. These data from individuals under 50 years of age are evidence that smoking is accompanied by changes in lipoprotein cholesterols that are potentially atherogenic. As the smoking variable used in Table 9 is the actual number of cigarettes smoked, a dose-response effect is present. A different situation holds in those over 50 years of age. Only HDL-C was significantly associated with cigarette number and the other lipoprotein fractions showed no independent associations when alcohol intake and were also in the model. Table 12. Regression Coefficients of Plasma Chemistry, Hematologic, and Selected Variables for VLDL Cholesterol in Framlngham Offspring Years Variable Current smoking (kg/sq m) (oz/wk) Albumin (g/100 ml) Alkaline phosphatase (lu/liter) Urea nitrogen (mg/100 ml) Calcium (mg/dl) Globulin (g/100 ml) Glucose (mg/100 ml) Hematocrit (ml/100 ml) LDH (U/ml) Phosphorus (mg/100 ml) SGOT (U/ml) Uric acid (mg/100 ml) Leucocyte count (1000/ml) Number * < p < fo.001 < p< : * * 0.154: : 1.234: 0.15 Men 0.664: 0.07* 2.89t 0.154: 0.05* 2.894: 1.51* : t 0.07* -0.34* : * 1.534: 0.44t 0.11 Women 2.13* -3.33* 0.08* -0.33* 0.08* -1.40* 1.68* 0.52* 0.11
7 ASSOCIATIONS WITH LIPOPROTEIN CHOLESTEROLS Wilson et al. 279 and the maintain an inverse association with HDL-C in all s, while alcohol intake has the opposite effect. Obesity is the only variable that shows consistently positive associations in the prediction of LDL-C and VLDL-C for this population. Previously reported results for the Offspring men and women under 50 emphasized the importance of obesity in young adults and its strong association with LDL-C and VLDL-C. 2 These results suggest that obesity is negatively associated with HDL-C both in the younger individuals and those over 50 years, and agrees with the LRC findings. 9 On the other hand, our data suggest that increasing age mitigates the associations of obesity with LDL-C and VLDL-C, and that obesity is less strongly associated with different levels of these lipoprotein cholesterol fractions in those over 50 years. The relationship of these lipoprotein cholesterols to alcohol intake deserves special mention. As in the LRC study, highly significant associations of alcohol consumption and HDL-C were observed. 910 Evidence from the LRC suggests that LDL-C and VLDL- C are also positively related to alcohol intake in teenagers. 10 In our population we found moderate, but significant, negative associations between alcohol intake and LDL-C in young men and women, and generally insignificant associations with VLDL-C. Cigarette smoking is accepted as an important risk factor for cardiovascular disease, but mechanisms to explain the association remain obscure. While certain evidence may favor an effect of short duration on cardiac function rather than more fundamental changes in the atherosclerotic process, the associations demonstrated in this report suggest that the composition of the lipoprotein cholesterol fractions is altered in young adult cigarette smokers. Various effects of smoking on lipids have been reported. They include an increase in total cholesterol, 11 a decrease or no effect in HDL-C, 12> 13 and an increase in LDL-C. 14 ' 15 In our results the positive coefficients for LDL-C and VLDL-C, and negative coefficients for HDL-C with smoking, are of interest. For HDL-C, multiple regression coefficients for smoking in this study are for men and for women. Corresponding values from the LRC investigations for men were for light smokers (1 to 19 cigarettes per day), and -5.3 for heavy smokers (more than 19 cigarettes per day), while the LRC values for women were -4.5 for light smokers and -8.6 for heavy smokers. Similar sorts of deductions can be made using the coefficients in Table 9. For example, a man under 50 years of age who smokes 20 cigarettes a day would be predicted to have an HDL-C 2.2 mg/dl less and a LDL-C 3.2 mg/dl greater than a similar nonsmoker of the same sex. The magnitude of these changes is less than that reported by the LRC, but in the same direction. Furthermore, these analyses demonstrate differences in LDL-C and VLDL-C fractions in smokers over 50 years of age. Taken with previous stud- Tables 10 to 12 display the multiple regression models for the lipoprotein cholesterols regressed on an additional set of independent variables. The results are shown for all the variables considered and separately for those variables that remain significant after a backward stepwise selection process was completed. From the latter analysis, calcium, uric acid, leucocyte count, alkaline phosphatase, smoking, alcohol, and were significantly associated with HDL-C levels for both sexes (Table 10). In Table 11,, calcium, hematocrit, LDH, and leucocyte count were associated with LDL-C for both sexes. Slightly different results were obtained in Table 12. VLDL-C was associated with alkaline phosphatase, glucose, uric acid, and leucocyte count in both sexes. Several other associations between the lipoprotein cholesterols and the clinical chemistry determinations also occurred for each sex separately. Discussion Earlier publications have explored the interrelationships of smoking, obesity, and alcohol intake with lipoprotein cholesterol measurements. The age range and large number of participants in this report allow assessment of effects not studied in previous investigations. The first two tables provide background information. frequency declines for each gender with each succeeding age in our population. Men drink more than twice as much alcohol per week as the women for each age, and alcohol intake peaks between 40 and 59 years of age in both men and women. The data provided by the smoking frequencies, levels, and mean alcohol intake are analyzed further in Tables 3-8. A close examination of Tables 3 and 4 illustrate some of these findings. For instance, in the prediction of HDL-C for the total male and female population, the various coefficients differ for smoking and alcohol intake, but are almost the same for the. These coefficients have direct clinical application. Male smokers have HDL-C levels 3.2 mg/dl less than nonsmoking men. A oneunit increase in the approximates a 5 Ib increase in weight, and is associated with approximately a 0.8 mg/dl decrease in HDL-C. Similarly, a 1 oz/wk increase in alcohol consumption is associated with an HDL-C elevation of 0.4 mg/dl. The age-specific regression analyses yield slightly different results. There are fewer participants in the older age s, and prediction equations are less reliable. The smaller multiple values indicate that the association of the independent variables with the lipoprotein cholesterols are not as strong. Some findings are very consistent, though. The relationship of the independent variables to HDL-C are consistent across age s.
8 280 ARTERIOSCLEROSIS VOL 3, No 3, MAY/JUNE 1983 ies, these results suggest that current smoking may alter lipoprotein cholesterol metabolism; that there is a dose-response effect for the number of cigarettes smoked on HDL-C, LDL-C, and VLDL-C in adults under 50; and that cigarette number may have a greater impact on HDL-C in women than in men. 12 ' 16 The regressions in Tables 10 to 12 with the automated chemistry data complement similar reports of lipoprotein cholesterol levels. 17 Calcium is strikingly associated with higher HDL-C levels, while alkaline phosphatase, uric acid, and leucocyte counts exhibit negative associations. The association between calcium and cholesterol levels has been noted before. 13 These data include individuals whose calcium levels ranged from 7.6 to 11.2 mg/dl. When the same regression was run after stratification by low, middle, and high calcium levels, uniform associations of HDL-C with calcium were still observed. Elevated SGOT levels and low alkaline phosphatase levels have been linked to elevated HDL-C levels In our data, SGOT is not significantly related to HDL-C values, while the association of alkaline phosphatase and HDL-C is negative, as in the LRC results. The pathophysiology underlying these associations remains obscure. Recent data suggest that chronicity and level of alcohol intake are related to HDL-C levels. 19 This sort of information and further data about muscle, liver, and bone metabolism may be needed to sort out these biochemical relationships to HDL-C. Apart from the, serum calcium, LDH, hematocrit, and leucocyte count are also significantly related to LDL-C in men and women. There is no obvious explanation why this set of variables has such an association. The role of other variables is enigmatic; i.e., that of albumin, where a 1 g/liter increase is associated with a 10 mg/dl lower LDL-C level in men, but no change in women. For both men and women, the variables, alkaline phosphatase, glucose, uric acid, and leucocyte count, are independently associated with VLDL-C. Elevations of glucose and uric acid in one study, 20 and glucose, obesity, and prebeta lipoproteins in another 21 have been suggested as covariates that may herald glucose intolerance or diabetes mellitus. The association of the lipoprotein cholesterols and the leucocyte count merits special comment. Greater leucocyte count has been reported as a risk factor for myocardial infarction in an earlier publication. 22 A follow-up investigation suggested that the effect was obtained only in smokers. 23 The data in Tables 10 to 12 further suggest that greater leucocyte counts are associated with a more atherogenic lipid profile: lower HDL-C and greater LDL-C and VLDL-C levels. These associations with the leucocyte count also exist when an analysis is performed on only nonsmokers. Earlier research has hinted that disease states, medication use, and environmental variables may affect levels of lipoprotein cholesterols. This report has highlighted some of these features, emphasizing common environmental variables, but includes less commonly measured factors as well. From a different perspective, the analyses undertaken in this study freshen our thoughts about the potential effects on lipoprotein cholesterol measurements, and reactivates our interest in factors such as liver function, leucocyte count, and calcium levels which might have bearing on the atherosclerotic process. References 1. Castelll WP, Gordon T, Hjortland MC, et al. and blood liplds: The Cooperative Lipoprotein Phenotyplng Study. Lancet 1977;2: Garrison RJ, Wilson PW, Caatelll WP, Felnlelb M, Kannel WB, McNamara P. Obesity and lipoprotein cholesterol in the Framingham Offspring Study. Metabolism 1980;29: Helss G, Johnson NJ, Relland S, et al. The epidemiology of plasma high-density lipoprotein cholesterol levels. The LJpid Research Clinics Program Prevalence Study. Summary. Circulation 1980;62(Suppl (V):IV-116-IV LlpkJ Research Clinics Program. Manual of Laboratory Operation, vol. 1: LJpid and lipoprotein analysis. DHEW publication no. (NIH) Bethesda, Maryland: National Institutes of Health 5. Hjortland MC, Felnlelb M. Epidemlologjc relationships of alcohol intake and coronary heart disease: results from NHLBI programs. In: Avogaro P, Sirtori CR, Tremoli E, eds. Metabolic effects of alcohol. New York: Elsevier/North Holland Biomedical Press, 1979: Aboil LL, Levy BB, Brodle BB, Kendall FE. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 1952;195: Kessler G, Lederer H. Fluorometric measurements of triglycerfdes. In: Skegg LT Jr. ed. Technicon symposium: Automation In analytical chemistry, New York: Medical Inc, 1966: Neter J, Wasserman W. Applied linear statistical models. Illinois: Richard D. Irwin Press, 1974: Glueck CJ, Taylor HL, Jacobs D, Morrison JA, Beaglehole R, Williams OD. Plasma high-density lipoprotein cholesterol: Association with measurements of body mass. Circulation 1980;62 (Suppl IV):IV-62-IV Glueck CJ, Helss G, Morrison JA, Khoury P, Moore M. intake, cigarette smoking and plasma llpkjs and lipoproteins in year old children. The Collaborative LJpid Research Clinics Prevalence Study. Circulation 1981;64 (Suppl lll):lll-48-lll McGIII HC Jr. Potential mechanisms for the augmentation of atherosclerosis and atherosclerotic disease by cigarette smoking. Prev Med 1979;8: Garrison RJ, Kannel WB, Felnlelb M, Castelll WP, McNamara PM, Padgett SJ. Cigarette smoking and HDL cholesterol: The Framingham Offspring Study. Atherosclerosis 1978;30: Phillips NR, Havel RJ, Kane JP. Levels and interrelationships of serum and lipoprotein cholesterol and triglycerides. Association with adiposity and the consumption of ethanol, tobacco, and beverages containing caffeine. Arteriosclerosis 1981;1: Heyden S, Helss G, Manegold C, et al. The combined effect of smoking and coffee drinking on LDL and HDL cholesterol. Circulation 1979:60: Garrison RJ, Castelll WP, Felnlelb M, et al. The association
9
10 Factors associated with lipoprotein cholesterol levels. The Framingham study. P W Wilson, R J Garrison, R D Abbott and W P Castelli Arterioscler Thromb Vasc Biol. 1983;3: doi: /01.ATV Arteriosclerosis, Thrombosis, and Vascular Biology is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX Copyright 1983 American Heart Association, Inc. rights reserved. Print ISSN: Online ISSN: The online version of this article, along with updated information and services, is located on the World Wide Web at: published Permissions: Requests for permissions to reproduce figures, tables, or portions of articles originally in Arteriosclerosis, Thrombosis, and Vascular Biology can be obtained via RightsLink, a service of the Copyright Clearance Center, not the Editorial Office. Once the online version of the published article for which permission is being requested is located, click Request Permissions in the middle column of the Web page under Services. Further information about this process is available in the Permissions and Rights Question and Answer document. Reprints: Information about reprints can be found online at: Subscriptions: Information about subscribing to Arteriosclerosis, Thrombosis, and Vascular Biology is online at:
High Density Lipoprotein Cholesterol and Mortality
High Density Lipoprotein Cholesterol and Mortality The Framingham Heart Study Peter W.F. Wilson, Robert D. Abbott, and William P. Castelli In 12 years of follow-up for 2748 Framingham Heart Study participants
More informationThe investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India
eissn: 09748369, www.biolmedonline.com The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India M Estari, AS Reddy, T Bikshapathi,
More informationChemistry Reference Ranges and Critical Values
Alanine Aminotransferase (ALT, SGPT) 3-9 years 9-18 years 1-9 years 9-18 years 10-25 U/L 10-35 U/L 10-30 U/L 10-25 U/L 10-30 U/L 10-35 U/L 10-25 U/L 10-35 U/L 10-25 U/L 10-20 U/L 10-35 U/L Albumin 0-6
More informationChemistry Reference Ranges and Critical Values
Alanine Aminotransferase (ALT, SGPT) 3-9 years 9-18 years 1-9 years 9-18 years 10-30 U/L 10-30 U/L 10-20 U/L Albumin 0-6 days 6 days - 37 months 37 months - 7 years 7-20 years 2.6-3.6 g/dl 3.4-4.2 g/dl
More informationThe Framingham Coronary Heart Disease Risk Score
Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although
More informationThe Best Lipid Fraction for the Prediction of the Population at Risk of Atherothrombotic Disease. William E. Feeman, Jr., M.D.
The Best Lipid Fraction for the Prediction of the Population at Risk of Atherothrombotic Disease William E. Feeman, Jr., M.D. 640 South Wintergarden Road Bowling Green, Ohio 43402 Phone 419-352-4665 Fax
More informationModerate alcohol consumption is associated with decreased
Alcohol Consumption and Plasma Concentration of C-Reactive Protein Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Moderate alcohol intake has been associated with
More informationSecular Trends in Alcohol Consumption over 50 Years: The Framingham Study
CLINICAL RESEARCH STUDY Secular Trends in Alcohol Consumption over 50 Years: The Framingham Study Yuqing Zhang, DSc, a,b Xinxin Guo, MPH, a c,d a,e Richard Saitz, MD, MPH, Daniel Levy, MD, MPH, Emily Sartini,
More informationThe Whitehall II study originally comprised 10,308 (3413 women) individuals who, at
Supplementary notes on Methods The study originally comprised 10,308 (3413 women) individuals who, at recruitment in 1985/8, were London-based government employees (civil servants) aged 35 to 55 years.
More informationPreventing Myocardial Infarction in the Young Adult in the First Place: How Do the National Cholesterol Education Panel III Guidelines Perform?
Journal of the American College of Cardiology Vol. 41, No. 9, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00187-6
More informationORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationMultiphasic Blood Analysis
Understanding Your Multiphasic Blood Analysis Test Results Mon General thanks you for participating in the multiphasic blood analysis. This test can be an early warning of health problems, including coronary
More information2.0 Synopsis. Choline fenofibrate capsules (ABT-335) M Clinical Study Report R&D/06/772. (For National Authority Use Only) Name of Study Drug:
2.0 Synopsis Abbott Laboratories Individual Study Table Referring to Part of Dossier: (For National Authority Use Only) Name of Study Drug: Volume: Choline Fenofibrate (335) Name of Active Ingredient:
More informationThe recently released American College of Cardiology
Data Report Atherosclerotic Cardiovascular Disease Prevention A Comparison Between the Third Adult Treatment Panel and the New 2013 Treatment of Blood Cholesterol Guidelines Andre R.M. Paixao, MD; Colby
More informationCHOLESTEROL AND CORONARY ARTERY DISEASE: AGE AS AN EFFECT MODIFIER
CHOLESTEROL AND CORONARY ARTERY DISEASE: AGE AS AN EFFECT MODIFIER By: Steven J. Jacobsen, David S. Freedman, Raymond G. Hoffmann, Harvey W. Gruchow, Alfred J. Anderson, and Joseph J. Barboriak Jacobsen
More informationPaul S. Bachorik,' Robert E. Walker, and Peter 0. Kwiterovich, Jr.
papers and notes on methodology Determination of high density lipoprotein-cholesterol in human plasma stored at -7OOC Paul S. Bachorik,' Robert E. Walker, and Peter 0. Kwiterovich, Jr. Departments of Pediatrics
More informationDiabetologia 9 Springer-Verlag 1991
Diabetologia (1991) 34:590-594 0012186X91001685 Diabetologia 9 Springer-Verlag 1991 Risk factors for macrovascular disease in mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationDefining Severe Familial Hypercholesterolemia. Raul D. Santos MD, PhD Brazil
Defining Severe Familial Hypercholesterolemia Raul D. Santos MD, PhD Brazil 1 Disclosure Honoraria received for consulting, speaker and or researcher activities : Astra Zeneca, Akcea, Amgen, Biolab, Esperion,
More informationApplicability of Cholesterol-Lowering Primary Prevention Trials to a General Population
Applicability of Cholesterol-Lowering Primary Prevention Trials to a General Population The Framingham Heart Study ORIGINAL INVESTIGATION Donald M. Lloyd-Jones, MD; Christopher J. O Donnell, MD, MPH; Ralph
More informationThe New England Journal of Medicine ASSOCIATION BETWEEN MULTIPLE CARDIOVASCULAR RISK FACTORS AND ATHEROSCLEROSIS IN CHILDREN AND YOUNG ADULTS
ASSOCIATION BETWEEN MULTIPLE CARDIOVASCULAR RISK FACTORS AND ATHEROSCLEROSIS IN CHILDREN AND YOUNG ADULTS GERALD S. BERENSON, M.D., SATHANUR R. SRINIVASAN, PH.D., WEIHANG BAO, PH.D., WILLIAM P. NEWMAN
More informationAndrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION
2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL
More informationJournal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.043
More informationScreening for Total Cholesterol
1287 Screening for Total Cholesterol Do the National Cholesterol Education Program's Recommendations Detect Individuals at High Risk of Coronary Heart Disease? Trudy L. Bush, PhD, MHS, and Denise Riedel,
More informationRosuvastatin: An Effective Lipid Lowering Drug against Hypercholesterolemia
ISPUB.COM The Internet Journal of Cardiovascular Research Volume 3 Number 1 Rosuvastatin: An Effective Lipid Lowering Drug against Hypercholesterolemia V Save, N Patil, G Rajadhyaksha Citation V Save,
More informationHIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES
HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES A study published in the British Medical Journal shows that not only is high LDL cholesterol not a risk factor for all-caused
More informationCardiovascular Disease
8 High-Density Lipoprotein Cholesterol and Cardiovascular Disease Four Prospective American Studies David J. Gordon, MD, PhD, Jeffrey L. Probstfield, MD, Robert J. Garrison, MS, James D. Neaton, PhD, William
More informationHigh density lipoprotein cholesterol and longevity.
Journal of Epidemiology and Community Health, 1987, 42, 60-65 High density lipoprotein cholesterol and longevity. ANCEL KEYS From the Division of Epidemiology, School of Public Health, University of Minnesota,
More informationHDL-C. J Jpn Coll Angiol, 2008, 48: NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart
Online publication March 25, 2009 48 6 2007 2007 HDL-C LDL-C HDL-C J Jpn Coll Angiol, 2008, 48: 463 470 NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart 1987 NIPPON DATA80 Iso 10 MRFIT
More informationThe importance of both low-density lipoprotein
Improving the Prediction of Cardiovascular Risk: Interaction Between LDL and HDL Cholesterol Steven A. Grover, 1,2,3,4 Marc Dorais, 1,3 and Louis Coupal 1,3 Background. The ratio of total cholesterol to
More informationEpidemiology of Blood Lipids and Lipoproteins
Epidemiology of Blood Lipids and Lipoproteins 2 Peter W.F. Wilson Introduction Research has shown that total cholesterol levels in the blood are highly associated with greater coronary heart disease (CHD)
More informationCoronary artery occlusion and alcohol intake
British Heart journal, 1977, 39, 289-293 Coronary artery occlusion and alcohol intake JOSEPH J. BARBORIAK, ALFRED A. RIMM, ALFRED J. ANDERSON, MARK SCHMIDHOFFER, AND FELIX E. TRISTANI From the Research
More information1. Which one of the following patients does not need to be screened for hyperlipidemia:
Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:
More informationANNALS of Internal Medicine
ANNALS of Internal Medicine AUGUST 1978 VOLUME 89 NUMBER 2 Published Monthly by the American College of Physicians Menopause and Coronary Heart Disease The Framingham Study TAVIA GORDON; WILLIAM B. KANNEL,
More informationLife Science Journal 2018;15(12)
Multicenter observational study of risk factors profile in a sample of Egyptian Patients with Acute Coronary Syndrome (part of Egyptian Cardiovascular Risk Factors Project) Prof. Dr. Ahmed Ashraf Reda,
More informationIs Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea
Is Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea Hyuncheol Bryant Kim 1, Suejin A. Lee 1, and Wilfredo Lim 2 1 Cornell University
More informationSUPPLEMENTAL MATERIAL. Materials and Methods. Study design
SUPPLEMENTAL MATERIAL Materials and Methods Study design The ELSA-Brasil design and concepts have been detailed elsewhere 1. The ELSA-Brasil is a cohort study of active or retired 15,105 civil servants,
More informationGeneral Chemistry Scheme Guide
General Chemistry Scheme Guide Copyright WEQAS. All rights reserved. No part of this document may be reproduced or utilised in any form without permission from WEQAS Contents. Scheme details and repertoire.....
More informationClinical Recommendations: Patients with Periodontitis
The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;
More informationHigh-Normal Blood Pressure Progression to Hypertension in the Framingham Heart Study
22 High- Blood Pressure Progression to Hypertension in the Framingham Heart Study Mark Leitschuh, L. Adrienne Cupples, William Kannel, David Gagnon, and Aram Chobanian This study sought to determine if
More informationEFFECT OF NICARDIPINE ON FASTING PLASMA LIPIDS AND APOLIPOPROTEINS IN MALE NEW ZEALAND WHITE RABBITS. Kamsiah Jaarin, Nafeeza MI*
REVIEW ARTICLE Malaysian Journal of Medical Sciences, Vol. 6, No. 2, July 1999 (5-11) EFFECT OF NICARDIPINE ON FASTING PLASMA LIPIDS AND APOLIPOPROTEINS IN MALE NEW ZEALAND WHITE RABBITS Kamsiah Jaarin,
More informationClinical Study of Lipid Profile Pattern in Acute Coronary Syndromes
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2017/359 Clinical Study of Lipid Profile Pattern in Acute Coronary Syndromes V Suresh Kumar, Madavaram Sreelatha Assistant
More informationLongitudinal Trajectories of Cholesterol from Midlife through Late Life according to Apolipoprotein E Allele Status
Int. J. Environ. Res. Public Health 2014, 11, 10663-10693; doi:10.3390/ijerph111010663 OPEN ACCESS Article International Journal of Environmental Research and Public Health ISSN 1660-4601 www.mdpi.com/journal/ijerph
More informationIntermittent claudication (IC) is a clinical manifestation of
Alcohol Consumption and Risk of Intermittent Claudication in the Framingham Heart Study Luc Djoussé, MD, MPH; Daniel Levy, MD; Joanne M. Murabito, MD, MS; L. Adrienne Cupples, PhD; R. Curtis Ellison, MD
More informationIntermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis
Intermediate Methods in Epidemiology 2008 Exercise No. 4 - Passive smoking and atherosclerosis The purpose of this exercise is to allow students to recapitulate issues discussed throughout the course which
More informationReview of the evidence linking alcohol consumption with liver disease and atherosclerotic disease
Review of the evidence linking alcohol consumption with liver disease and atherosclerotic disease Norton Spritz, 2 M.D. Introduction and scope of the review of alcohol ingestion and disease This report
More informationRisk Factors for Heart Disease
Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress
More informationCOMMITTEE ON NUTRITION
COMMITTEE ON NUTRITION CHILDHOOD DIET AND CORONARY HEART DISEASE A SUBCOMMITTEE of the Inter-Society Commission for Heart Disease Resources recently recommended an immediate, nationwide change in dietary
More informationStroke A Journal of Cerebral Circulation
Stroke A Journal of Cerebral Circulation JULY-AUGUST VOL. 7 1976 NO. 4 Components of Blood Pressure and Risk of Atherothrombotic Brain Infarction: The Framingham Study WILLIAM B. KANNEL, M.D., THOMAS R.
More informationORIGINAL INVESTIGATION. Relation of Triglyceride Levels, Fasting and Nonfasting, to Fatal and Nonfatal Coronary Heart Disease
ORIGINAL INVESTIGATION Relation of Triglyceride Levels, Fasting and Nonfasting, to Fatal and Nonfatal Coronary Heart Disease Lynn E. Eberly, PhD; Jeremiah Stamler, MD; James D. Neaton, PhD; for the Multiple
More informationPage down (pdf converstion error)
1 of 6 2/10/2005 7:57 PM Weekly August6, 1999 / 48(30);649-656 2 of 6 2/10/2005 7:57 PM Achievements in Public Health, 1900-1999: Decline in Deaths from Heart Disease and Stroke -- United States, 1900-1999
More informationClinician Blood Panel Results
Page 1 of 8 Blood Panel - Markers Out of Range and Patterns (Pattern: proprietary formula using one or more Blood Markers) Blood Panel: Check for Markers that are out of Lab Range ***NOTE*** Only one supplement
More informationStudy of serum Lipid Profile patterns of Indian population in young Ischaemic Heart Disease
Original article: Study of serum Lipid Profile patterns of Indian population in young Ischaemic Heart Disease Dr Sonu Yadav, Dr Abhijit Nikam, Dr Vivek Chiddarwar, Dr A L Kakrani Department of Medicine,
More informationCardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az
Cardiometabolics in Children or Lipidology for Kids Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az No disclosures for this Presentation Death Risk Approximately 40% of
More informationMethods. 336 ARTERIOSCLEROSIS VOL 2, No 4, JULY/AUGUST 1982
3 ARTERIOSCLEROSIS VOL 2, No 4, JULY/AUGUST 82 lipoprotein abnormalities, Fredrickson and coworkers 4 and later the World Health Organization (WHO) 5 recognized six types of hyperlipoproteinemias that
More informationCurrent Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD
Current Cholesterol Guidelines and Treatment of Residual Risk J. Peter Oettgen, MD Associate Professor of Medicine Harvard Medical School Director, Preventive Cardiology Beth Israel Deaconess Medical Center
More informationThe purpose of this report is to compare the results of
Comparison of Two Measures of Atherosclerosis in a Prospective Epidemiology Study Dwayne M. Reed, Jack P. Strong, Takuji Hayashi, W. P. ewman III, Richard E. Tracy, Miguel A. Guzman, and Grant. Stemmermann
More informationEpidemiologic and clinical comparison of renal artery stenosis in black patients and white patients
ORIGINAL ARTICLES Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients Andrew C. Novick, MD, Safwat Zald, MD, David Goldfarb, MD, and Ernest E. Hodge, MD,
More informationFamily history of heart attack: a modifiable risk
PATHOPHYSIOLOGY AND NATURAL HISTORY CORONARY ARTERY DISEASE Family history of heart attack: a modifiable risk factor? KAY-TEE KHAW, M.Sc., M.R.C.P., AND ELIZABETH BARRETT-CONNOR, M.D. ABSTRACT A family
More informationWhat Does My Blood Test Mean
What Does My Blood Test Mean CBC with Differential This means that your doctor wants to know the amounts and proportions among the various components of your blood, explained below. The term differential
More informationBehind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL
Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Sung-Joon Lee, PhD Division of Food Science Institute of Biomedical Science and Safety Korea University Composition of Lipoproteins:
More informationAtherosclerotic Disease Risk Score
Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,
More informationNew Features of the National Cholesterol Education Program Adult Treatment Panel III Lipid-Lowering Guidelines
Clin. Cardiol. Vol. 26 (Suppl. III), III-19 III-24 (2003) New Features of the National Cholesterol Education Program Adult Treatment Panel III Lipid-Lowering Guidelines H. BRYAN BREWER, JR, M.D. Molecular
More informationCardiovascular Disease Risk Factors:
Cardiovascular Disease Risk Factors: Risk factors are traits or habits that increase a person's chances of having cardiovascular disease. Some risk factors can be changed. These risk factors are high blood
More informationHOW TO CITE THIS ARTICLE:
THE EFFECT OF PHYSICAL ACTIVITY AND ATORVASTATIN ACTION ON LIPID PROFILE OF AND NON ALCOHOLIC MYOCARDIAL INFARCTION PATIENTS D. Syamala 1, N. Indira Kumari 2, G. Teja Pavan 3 HOW TO CITE THIS ARTICLE:
More informationSerum Uric Acid Levels and the Risk of Type 2 Diabetes: A Prospective Study
CLINICAL RESEARCH STUDY Serum Uric Acid Levels and the Risk of Type 2 Diabetes: A Prospective Study Vidula Bhole, MD, MHSc, a Jee Woong J. Choi, a Sung Woo Kim, a Mary de Vera, MSc, a,b Hyon Choi, MD,
More informationAccuracy and Precision in Point-of-Care Lipid Testing: CardioChek P A Point-of-Care Test System and PTS Panels Test Strips
Accuracy and Precision in Point-of-Care Lipid Testing: CardioChek P A Point-of-Care Test System and PTS Panels Test Strips Sponsored by Arthur Roberts, MD of The Living Heart Foundation The Living Heart
More information5/6/ :35:00AM 5/6/ :57:28AM 5/6/2017 3:49:09PM A/c Status. Test Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 136235211 Age Unknown Gender Unknown 5/6/2017 103500AM 5/6/2017 105728AM 5/6/2017 34909M Ref By Final Swasth lus Health Advance anel LIVER & KIDNEY ANEL, SERUM (Spectrophotometry,
More informationSMOKING CESSATION EFFECTS ON BODY WEIGHT, HAEMOGLOBIN, TOTAL AND HDL CHOLESTEROL AND BLOOD PRESSURE
SMOKING CESSATION EFFECTS ON BODY WEIGHT, HAEMOGLOBIN, TOTAL AND HDL CHOLESTEROL AND BLOOD PRESSURE *Mohammed Ghouse S. Department of Zoology, Osmania College (NAAC Accredt. A Grade), Kurnool, A.P, India
More informationAnalyte Specimen Demographic Reference Range Units
Acetone Negative titer Alanine aminotransferase (ALT/SGPT) 10-49 U/L Albumin 3.2-4.8 g/dl Alcohol < 10 Alpha-fetoprotein (AFP) < 1.3-8.1 ng/ml Alkaline phosphatase 0 7 days 7 30 days 1 3 3 6 6 12 1 3 3
More informationCLINICAL CHEMISTRY REAGENTS. Product Profile
Product Profile Why Clinical Chemistry Reagents? Quantitative determination of specific analytes associated with various types of disease. Diagnosis Identifying a disease already present Prognosis Forecasting
More informationKatsuyuki Nakajima, PhD. Member of JCCLS International Committee
Katsuyuki Nakajima, PhD Member of JCCLS International Committee Visiting Professor and Scientist Tufts University, Boston, MA & Framingham Offspring Study, Framingham, MA August 20 th, 2011, Tokyo Framingham
More informationRheological Properties of Erythrocytes and Lipid Profiles of Blood Plasma
IBIMA Publishing JMED Research http://www.ibimapublishing.com/journals/jmed/jmed.html Vol. 2015 (2015), Article ID 563217, 5 pages DOI: 10.5171/2015.563217 Research Article Rheological Properties of Erythrocytes
More informationBiases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University
Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of
More informationClinician Blood Panel Results
Page 1 of 7 Blood Panel - Markers Out of Range and Patterns (Pattern: proprietary formula using one or more Blood Markers) Blood Panel: Check for Markers that are out of Lab Range ***NOTE*** Only one supplement
More informationKnow Your Numbers. Your guide to maintaining good health. Helpful information from Providence Medical Center and Saint John Hospital
Know Your Numbers Your guide to maintaining good health Helpful information from Providence Medical Center and Saint John Hospital If it has been awhile since your last check up and you are searching for
More informationAssociation of Plasma Lipid profile and HbA1c among Saudi Patients with Coronary Heart Diseases, at King Abdulaziz Medical City, Riyadh
EUROPEAN ACADEMIC RESEARCH Vol. III, Issue 10/ January 2016 ISSN 2286-4822 www.euacademic.org Impact Factor: 3.4546 (UIF) DRJI Value: 5.9 (B+) Association of Plasma Lipid profile and HbA1c among Saudi
More informationROTUNDA HOSPITAL DEPARTMENT OF LABORATORY MEDICINE
This active test table informs the user of Biochemistry tests available in house. s referred to other sites are recorded in the Referred Table. Issue date: 4 TH April 2016 Contact Phone Number ext.1345/2522
More informationSupplementary Note Details of the patient populations studied Strengths and weakness of the study
Supplementary Note Details of the patient populations studied TVD and NCA patients. Patients were recruited to the TVD (triple vessel disease) group who had significant coronary artery disease (defined
More informationDisclosures. Background 1 What is Known MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES. Background 2 What is Not Known 10/2/2017
Disclosures MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES Grants: NIH, Quest Diagnostics Consultant: Quest Diagnostics Merck Global Atherosclerosis Advisory Board Ronald M. Krauss, Children s Hospital
More informationCardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009
Cardiovascular disease, studies at the cellular and molecular level Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009 Content Introduction The number 1 killer in America Some statistics
More informationClinical Trial Synopsis TL-OPI-518, NCT#
Clinical Trial Synopsis, NCT# 00225264 Title of Study: A Double-Blind, Randomized, Comparator-Controlled Study in Subjects With Type 2 Diabetes Mellitus Comparing the Effects of Pioglitazone HCl vs Glimepiride
More informationSociety for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA
Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA John M. Violanti, PhD* a ; LuendaE. Charles, PhD, MPH b ; JaK. Gu, MSPH b ; Cecil M. Burchfiel, PhD, MPH b ; Michael E. Andrew, PhD
More informationCardiovascular Disease
Cardiovascular Disease Controlling your risk factors WE RECOMMEND THAT YOU Monitor your blood pressure on a regular basis If you have high blood pressure, reduce your intake of salt, tea and coffee Drink
More informationCombined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women
European Heart Journal (2002) 23, 528 535 doi:10.1053/euhj.2001.2888, available online at http://www.idealibrary.com on Combined effects of systolic blood pressure and serum cholesterol on cardiovascular
More informationTables of Normal Values (As of February 2005)
Tables of Normal Values (As of February 2005) Note: Values and units of measurement listed in these Tables are derived from several resources. Substantial variation exists in the ranges quoted as normal
More informationSupplementary Online Content
Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia
More informationPlacebo-Controlled Statin Trials
PREVENTION OF CHD WITH LIPID MANAGEMENT AND ASPIRIN: MATCHING TREATMENT TO RISK Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of
More informationPeripheral Differential Leukocyte Counts in Humans Vary with Hyperlipidemia, Smoking, and Body Mass Index
Peripheral Differential Leukocyte Counts in Humans Vary with Hyperlipidemia, Smoking, and Body Mass Index Zei-Shung Huang a, *, Kuo-Liong Chien a, Chi-Yu Yang a, Keh-Sung Tsai b, and Chiu-Hwa Wang b Departments
More informationFasting or non fasting?
Vascular harmony Robert Chilton Professor of Medicine University of Texas Health Science Center Director of Cardiac Catheterization labs Director of clinical proteomics Which is best to measure Lower continues
More informationAssessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution
CLINICAL Viewpoint Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients Copyright Not for Sale or Commercial Distribution By Ruth McPherson, MD, PhD, FRCPC Unauthorised
More informationUpdate on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines
Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Paul Mahoney, MD Sentara Cardiology Specialists Lipid Management in Cardiovascular Disease
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and
More informationLipid/Lipoprotein Structure and Metabolism (Overview)
Lipid/Lipoprotein Structure and Metabolism (Overview) Philip Barter President, International Atherosclerosis Society Centre for Vascular Research University of New South Wales Sydney, Australia Disclosures
More informationCommunity health day. General Robert H. Reed Recreation Center 800 Gabreski Lane, Myrtle Beach Friday, May 11 7:30-10:30 a.m.
Community health day General Robert H. Reed Recreation Center 800 Gabreski Lane, Myrtle Beach Friday, May 11 7:30-10:30 a.m. Health screenings to be offered include: Chemistry profile...$20 TSH (thyroid
More information1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver)
I. TEST YOUR KNOWLEDGE OF CHOLESTEROL Choose the correct answer. 1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver) 2. Only
More informationLipoprotein Particle Profile
Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular
More informationMetabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology
Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient
More information